The Global Pharma Partnering Summit 2026 is scheduled for 2–3 November 2026 at JRC Conventions & Trade Fairs in Hyderabad, India. The two-day conference and exhibition will bring together pharmaceutical companies, biotechnology businesses, contract research organisations (CROs), contract development and manufacturing organisations (CDMOs), technology providers, investors and industry leaders to explore strategic partnerships across the pharmaceutical value chain.
Designed to encourage collaboration, innovation and business growth, the Global Pharma Partnering Summit 2026 will provide a platform for industry professionals to discuss pharmaceutical outsourcing, drug discovery, research and development, clinical trials, advanced manufacturing, artificial intelligence and international market opportunities. The event is intended to connect organisations seeking new business relationships with potential partners, technology providers and decision-makers.
With pharmaceutical companies increasingly looking for reliable manufacturing partners, efficient research services and digital solutions, the summit offers an opportunity to understand emerging industry requirements and explore collaborative business models. Professionals planning to attend can use the event to discover new technologies, exchange knowledge and develop relationships with stakeholders from India and international markets.
Global Pharma Partnering Summit 2026: Event Overview
The Global Pharma Partnering Summit 2026 will combine a business conference, industry exhibition, networking sessions and curated one-to-one partnering meetings. Its programme is designed to connect scientific innovation with commercial opportunities and help businesses identify potential collaborators across the pharmaceutical ecosystem.
The Global Pharma Partnering Summit 2026 is particularly relevant to pharmaceutical manufacturers, research companies, biotech startups, laboratory solution providers, investors and business development professionals interested in strengthening their industry networks.
What Is the Global Pharma Partnering Summit 2026?
The Global Pharma Partnering Summit 2026 is a pharmaceutical business event focused on developing strategic partnerships and supporting collaboration across research, manufacturing, technology and commercial operations. Unlike a conventional product exhibition, the summit combines knowledge-sharing sessions with opportunities for direct engagement between potential business partners.
Participants will be able to explore services and solutions that support different stages of pharmaceutical development, from early-stage drug discovery and preclinical research to clinical development, commercial manufacturing, regulatory compliance and market access. The event’s partnering format is intended to help attendees identify organisations whose expertise, services or technologies complement their own business objectives.
The summit also reflects the growing importance of cross-border cooperation in the pharmaceutical industry. Companies increasingly collaborate with specialist research providers, manufacturing partners, digital technology businesses and regulatory consultants to improve efficiency and expand their capabilities. By bringing these stakeholders together, the Global Pharma Partnering Summit 2026 aims to create an environment where professional discussions can develop into longer-term commercial relationships.
Global Pharma Partnering Summit 2026 Date and Venue
The Global Pharma Partnering Summit 2026 will take place on 2 and 3 November 2026 at JRC Conventions & Trade Fairs, Hyderabad, India. The venue and dates are listed on the event’s official website.
Hyderabad is an established destination for pharmaceutical research, biotechnology, life sciences and technology-led business development. Its pharmaceutical ecosystem includes research organisations, manufacturing companies, scientific institutions and technology providers, making the city a relevant location for a summit focused on partnerships across the drug development and manufacturing value chain.
The venue will provide the setting for conference sessions, exhibition activities and business networking. Visitors should check the official website before travelling for the latest information on entry arrangements, session timings, registration requirements and any changes to the programme.
International delegates and visitors from other Indian cities should also confirm their travel and accommodation plans in advance. Registration confirmation and official event communications should be used to verify the precise venue access details and schedule.
Global Pharma Partnering Summit 2026 Tickets and Registration Price
Registration for the Global Pharma Partnering Summit 2026 is paid, according to the available event listing. However, a single verified ticket price applicable to every attendee has not been established in the available event information. The final cost may depend on the pass category, registration terms and any special access included with the selected package.
Attendees should visit the official website to review the current delegate registration options. Before purchasing a pass, visitors should check whether it includes conference sessions, access to the exhibition floor, scheduled Pharma Connect meetings, networking activities and any additional benefits.
The summit also advertises an executive networking dinner exclusively for VIP pass holders. Anyone interested in this experience should confirm the precise package inclusions and price directly with the organiser rather than assume the dinner is included in every ticket.
Exhibitors and sponsors should enquire separately about booth availability, exhibition space, promotional packages and sponsorship opportunities. These commercial packages are different from standard visitor registration and may have separate conditions.
Global Pharma Partnering Summit 2026 Exhibitors and Participating Companies
The exhibition at the Global Pharma Partnering Summit 2026 is designed to showcase organisations serving different stages of the pharmaceutical value chain. The official exhibition information highlights drug discovery and development, CRO and clinical research services, CDMO and contract manufacturing, regulatory affairs, quality management, laboratory technologies, packaging, automation, supply chain and market access.
Participating organisations listed on the summit website include pharmaceutical businesses, scientific technology providers, research service companies and industry associations. Names appearing in the event’s participant information include Dr. Reddy’s Laboratories, Novartis, Pfizer, Amgen, Syngene International, Wockhardt, Solara Active Pharma Sciences, MedGenome, Haier Biomedical and Esco Lifesciences Group.
The published participant information should not be interpreted as a guarantee that every listed organisation will exhibit with a dedicated booth. Visitors should consult the organiser’s latest exhibitor directory to confirm individual participation and booth details.
Pharmaceutical Manufacturing and CDMO Solutions
Contract development and manufacturing organisations play an important role in helping pharmaceutical companies develop formulations, optimise manufacturing processes and scale production. At the Global Pharma Partnering Summit 2026, the manufacturing segment is intended to connect businesses interested in contract production, process development, quality systems and operational efficiency.
For pharmaceutical manufacturers, these discussions can help identify potential partners for production expansion, technology transfer and specialised manufacturing requirements. CDMO representatives can also use the summit to communicate their capabilities to prospective customers and explore new commercial relationships.
Drug Discovery, CROs and Clinical Research
Drug discovery and clinical research are essential components of pharmaceutical innovation. CROs support pharmaceutical and biotechnology companies with research services, clinical trial operations, data management and related development activities.
The Global Pharma Partnering Summit 2026 will provide a setting for discussions about research partnerships, clinical development and ways to improve the efficiency of pharmaceutical programmes. These topics are particularly relevant to biotechnology startups and established pharmaceutical companies seeking specialist expertise or additional research capacity.
Laboratory Technologies, Automation and Digital Solutions
Laboratory equipment, analytical instruments, automation systems and digital platforms are becoming increasingly important across pharmaceutical research and manufacturing. Solutions in these areas can support accurate testing, process monitoring, quality control and operational efficiency.
The summit’s exhibition will offer an opportunity to discover relevant technologies and engage with suppliers serving the pharmaceutical and life sciences industries. Digital health businesses and artificial intelligence providers can also explore how their solutions may address practical research, manufacturing and business challenges.
Regulatory Affairs, Quality and Supply Chain
Pharmaceutical companies must manage complex regulatory requirements, maintain quality standards and ensure the reliability of their supply chains. Regulatory consultants, quality specialists, logistics providers and cold-chain solution companies can help businesses address these operational needs.
The Global Pharma Partnering Summit 2026 brings these areas into a broader partnership-focused environment, allowing attendees to explore services that support compliance, distribution, market access and manufacturing continuity.
Global Pharma Partnering Summit 2026 Conference Schedule
The published agenda for the Global Pharma Partnering Summit 2026 includes keynote presentations, panel discussions, question-and-answer sessions, networking breaks and technical discussions. The conference programme covers two days, with the first day’s published sessions focusing on India’s role in global pharmaceutical outsourcing and the integration of artificial intelligence into pharmaceutical research and development.
For pharmaceutical companies, these meetings can create opportunities to evaluate research providers, discuss outsourcing requirements and identify potential manufacturing partners. For CROs, CDMOs and technology companies, they offer a route to introduce capabilities to relevant organisations and explore potential business leads.
Attendees should prepare a clear company profile, an overview of their products or services and specific objectives before attending. Businesses seeking partners may benefit from identifying their requirements in advance, while solution providers should be ready to explain their expertise, quality systems, delivery capabilities and commercial offering.
The Global Pharma Partnering Summit 2026 is therefore intended to support more focused engagement than informal networking alone. The value of each meeting will depend on the relevance of the participants, their business priorities and the follow-up activities completed after the event.
Why Attend the Global Pharma Partnering Summit 2026?
The summit may benefit pharmaceutical manufacturers, biotechnology companies, CROs, CDMOs, laboratory suppliers, investors, consultants and business development teams. Its combined conference and exhibition format allows visitors to learn about industry developments while exploring potential commercial relationships.
For senior executives, the event provides a setting to discuss outsourcing strategies, manufacturing capacity, investment opportunities and international expansion. Research and development professionals can explore developments in AI-enabled discovery, clinical research and data-driven decision-making. Procurement and supply chain professionals can connect with providers whose services support operational reliability and efficiency.
Startups may use the event to present their innovations, build industry connections and explore relationships with established companies. Exhibitors can use their participation to strengthen visibility, demonstrate products and services, and engage with potential customers.
The Global Pharma Partnering Summit 2026 can also help international businesses understand India’s pharmaceutical and life sciences ecosystem. However, successful partnerships are not guaranteed by attendance alone; businesses should assess prospective partners carefully and conduct appropriate commercial, technical and regulatory due diligence.
Global Pharma Partnering Summit 2026: Key Industry Topics
The Global Pharma Partnering Summit 2026 is expected to address several important themes shaping the pharmaceutical sector. These include strategic outsourcing, pharmaceutical manufacturing, artificial intelligence, clinical research, regulatory transformation, sustainability and investment. The official event website identifies these areas among its conference and exhibition themes.
Artificial intelligence is becoming an important consideration in drug discovery, clinical data analysis and pharmaceutical operations. Industry discussions around AI can help businesses understand potential applications, implementation challenges and the importance of reliable data and regulatory oversight.
Outsourcing is another significant area, as pharmaceutical companies assess external partners for research, development and manufacturing. Companies must balance cost, quality, speed, technical expertise and risk when selecting service providers. Industry networking can help them evaluate potential relationships and identify areas for collaboration.
Supply chain resilience and sustainability are also relevant to pharmaceutical businesses operating across international markets. Reliable sourcing, temperature-controlled distribution, operational continuity and responsible manufacturing practices all influence how pharmaceutical products reach customers and healthcare systems.
By bringing these subjects together, the Global Pharma Partnering Summit 2026 aims to encourage discussions that connect scientific progress with practical business requirements.
Who Should Visit the Global Pharma Partnering Summit 2026?
The event is relevant to professionals and organisations working across the pharmaceutical and biotechnology industries. Pharmaceutical manufacturers can explore outsourcing opportunities, manufacturing technologies and potential suppliers. CROs and CDMOs can connect with companies seeking research or production services.
Biotechnology startups and drug discovery companies may find opportunities to present their work and build relationships with investors, research institutions and commercial partners. Laboratory equipment suppliers, automation providers and digital technology businesses can engage with potential customers looking for solutions to improve research and operational performance.
Business development executives, procurement managers, regulatory affairs specialists, quality professionals and supply chain leaders may also benefit from the event’s networking and knowledge-sharing format. Investors and licensing professionals can use industry conversations to identify areas of commercial interest, subject to their own evaluation processes.
International delegates considering partnerships in India can use the summit to learn about potential service providers and understand the needs of the regional pharmaceutical ecosystem.
How to Prepare for Global Pharma Partnering Summit 2026
Visitors should begin by completing registration through the official event website and confirming the selected pass category. They should review the latest agenda, identify relevant sessions and verify whether any desired meetings require advance scheduling.
Companies looking for partners should prepare a concise business introduction, a list of collaboration priorities and relevant technical or commercial information. Exhibitors should confirm their booth arrangements, promotional requirements and participation details with the organiser.
Delegates travelling to Hyderabad should plan transportation and accommodation ahead of the event. International visitors should independently verify visa and travel requirements where applicable.
After the summit, businesses can follow up with relevant contacts, exchange requested information and arrange more detailed discussions. This preparation and follow-through can help attendees make better use of the networking opportunities available at the Global Pharma Partnering Summit 2026.
Conclusion
The Global Pharma Partnering Summit 2026 is scheduled for 2–3 November 2026 at JRC Conventions & Trade Fairs in Hyderabad. Combining conference sessions, exhibition opportunities, networking and curated business meetings, the event is designed to bring pharmaceutical and biotechnology stakeholders together to explore partnerships and industry developments.
From drug discovery and clinical research to contract manufacturing, artificial intelligence, laboratory technologies and supply chain solutions, the summit covers multiple areas of the pharmaceutical value chain. It offers companies an opportunity to showcase capabilities, discover potential service providers and discuss business opportunities with relevant industry professionals.
For pharmaceutical executives, researchers, investors, procurement teams, technology providers and business development specialists, the Global Pharma Partnering Summit 2026 may be a useful opportunity to build professional connections and explore future collaborations. Attendees should confirm ticket prices, participation details and the final agenda directly with the organiser before making travel or commercial commitments.
